Edwards Lifesciences Corp.

NYS : EW
Pharmaceuticals
Irvine CA
IW Best50N/A
2012 Revenue (US$ Millions)$1,900
2011 Revenue (US$ Millions)$1,679
Revenue Growth (%)13.17%
Net Income (US$ Millions)$293
Common Shares Outstanding (Millions)$114
Earnings Per Share (US$)$2.48
Total Equity (US$ Millions)$1,479
Profit Growth (%)23.87
Profit Margin (%)15.43%
Return On Equity (%)21.91%
Long Term Debt (US$ Millions)$189
Debt To Equity Ratio (%)0.13%
Market Capitalization (US$ Millions)$10,306
Total Assets (US$ Millions)$2,222
Return on Assets (%)14.8
Current Assets (US$ Millions)$1,292
Inventories (US$ Millions)$281
Current Liabilities (US$ Millions)$347
Cost of Goods Sold (US$ Millions)$495
Asset Turnover0.86
Inventory Turnover1.82